Skip to main content

Table 4 Logistic regression for mortality

From: Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience

Risk factors

p-value

OR

95% CI for OR

Lower

Upper

Age

0.22

2.15

0.64

7.27

Female gender

0.38

0.54

0.14

2.10

FIB-4

0.006

4.14

1.49

11.49

Albumin < 3.5

0.89

1.11

0.26

4.75

  1. p ≤ 0.05 is significant